Mithra Pharmaceuticals SA (MITRA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Mithra Pharmaceuticals SA (MITRA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7878
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the treatment of contraception and fertility, menopause and osteoporosis, gynecological infections and cancers, among others. Mithra offers its products in polymeric forms, sterile injectable products, and hormonal tablets. It also offers research, development and specialist manufacturing services. The company sells its products through a network of distributors in Belgium, France, Germany and Brazil, among others. Mithra is headquartered in Liege, Belgium.

Mithra Pharmaceuticals SA (MITRA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Equipment, Deal Details 10
Partnerships 10
Adamed Enters into Licensing Agreement with Mithra Pharma for Myring 10
Mayne Pharma Enters into Licensing Agreement with Mithra Pharma 11
Equity Offering 12
Mithra Pharma Raises USD90 Million in Private Placement of Shares 12
Mithra Pharma Raises USD29 Million in Private Placement of Shares 14
Mithra Pharmaceuticals SA – Key Competitors 15
Mithra Pharmaceuticals SA – Key Employees 16
Mithra Pharmaceuticals SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Sep 25, 2018: Mithra announces 2018 half year results 18
Mar 02, 2018: Mithra Reports 2017 Annual Results 23
Sep 21, 2017: Mithra Announces 2017 Half Year Results 28
Mar 02, 2017: Mithra Pharmaceuticals: Mithra reports 2016 annual results 29
Corporate Communications 32
Jan 06, 2017: Mithra Pharmaceuticals Appoints Christophe Marechal As Chief Financial Officer 32
Other Significant Developments 33
May 16, 2018: Mithra Announces Injectable Contract With MIDAS Pharma 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Mithra Pharmaceuticals SA, Medical Equipment, Key Facts, 2017 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Deals By Market, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Adamed Enters into Licensing Agreement with Mithra Pharma for Myring 10
Mayne Pharma Enters into Licensing Agreement with Mithra Pharma 11
Mithra Pharma Raises USD90 Million in Private Placement of Shares 12
Mithra Pharma Raises USD29 Million in Private Placement of Shares 14
Mithra Pharmaceuticals SA, Key Competitors 15
Mithra Pharmaceuticals SA, Key Employees 16
Mithra Pharmaceuticals SA, Subsidiaries 17

List of Figures
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Mithra Pharmaceuticals SA (MITRA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Adris grupa dd:企業の戦略・SWOT・財務分析
    Adris grupa dd - Strategy, SWOT and Corporate Finance Report Summary Adris grupa dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ImmusanT Inc-医療機器分野:企業M&A・提携分析
    Summary ImmusanT Inc (ImmusanT) is a drug company that discovers and develops therapies for celiac disease. The company’s pipeline products include Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT’s pipeline products are al …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tokuyama Corporation (4043)-エネルギー分野:企業M&A・提携分析
    Summary Tokuyama Corporation (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, me …
  • Fabric Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalon …
  • Ellex Medical Lasers Limited (ELX):企業の財務・戦略的SWOT分析
    Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …
  • Atriva Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Atriva Therapeutics GmbH (Atriva Therapeutics) is a developer of antiviral therapies that develops therapies against seasonal and pandemic influenza. The company develops ATR-001 drug candidate, a MEK inhibitor which targets influenza. It also offers repurposing existing MEK inhibitors, orig …
  • Hanwha Life Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cipher Pharmaceuticals Inc (CPH):企業の財務・戦略的SWOT分析
    Summary Cipher Pharmaceuticals Inc (Cipher) is a pharmaceutical company that develops skin care solutions. The company provides products such as actikerall, a topical solution indicated for the treatment of hyperkeratotic actinic keratosis; beteflam, a topical patch used for the treatment of mild to …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hopewell Holdings Ltd (54):企業の財務・戦略的SWOT分析
    Hopewell Holdings Ltd (54) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • The Arab Assurers Insurance Co.:企業の戦略・SWOT・財務情報
    The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report Summary The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Jackson Electric Membership Corporation:発電所・企業SWOT分析
    Jackson Electric Membership Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • BTG Plc (BTG):医療機器:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …
  • Empire Electric Association, Inc.:発電所・企業SWOT分析
    Empire Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Qurate Retail Inc (QRTEA):企業の財務・戦略的SWOT分析
    Qurate Retail Inc (QRTEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NEXTracker Inc:電力:M&Aディール及び事業提携情報
    Summary NEXTracker Inc (NEXTracker), a subsidiary of Flex Ltd, is a renewable energy company. The company is engaged in the design, development, and manufacture of single-axis solar trackers for the power plants. It offers services such as design and engineering, project management, installation, pe …
  • Merrimack Pharmaceuticals Inc (MACK):製薬・医療:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆